Discontinued — last reported Q3 '22

Investing

Acquisitions

Amphenol Acquisitions decreased by 7.1% to $289.00M in Q3 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2024), Acquisitions shows relatively stable performance with a -1.0% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ3 2022

How to read this metric

High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.

Detailed definition

This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...

Peer comparison

Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.

Metric ID: cf_acquisitions

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$1.35B$0.00$694.40M$0.00$74.50M$213.70M$0.00$113.20M$0.00$179.40M$677.80M$0.00$2.10B$0.00$56.60M$2.17B$311.00M$289.00M
QoQ Change-100.0%-100.0%+186.8%-100.0%-100.0%+277.8%-100.0%-100.0%>999%-85.7%-7.1%
YoY Change-94.5%-100.0%-100.0%-16.1%-100.0%-100.0%-91.6%-85.2%
Range$0.00$2.17B
CAGR-30.4%
Avg YoY Growth-85.9%
Median YoY Growth-97.2%
Current Streak2 quarters decline

Frequently Asked Questions

What is Amphenol's acquisitions?
Amphenol (APH) reported acquisitions of $289.00M in Q3 2025.
What is the long-term trend for Amphenol's acquisitions?
Over 3 years (2021 to 2024), Amphenol's acquisitions has grown at a -1.0% compound annual growth rate (CAGR), from $2.23B to $2.16B.
What does acquisitions mean?
Cash spent to acquire other companies or businesses, net of cash received in the deal.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.